BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24205960)

  • 1. Biological exposure metrics of beryllium-exposed dental technicians.
    Stark M; Lerman Y; Kapel A; Pardo A; Schwarz Y; Newman L; Maier L; Fireman E
    Arch Environ Occup Health; 2014; 69(2):89-99. PubMed ID: 24205960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.
    Fireman E; Lerman Y; Stark M; Pardo A; Schwarz Y; Van Dyke MV; Elliot J; Barkes B; Newman L; Maier L
    J Occup Environ Hyg; 2014; 11(12):809-18. PubMed ID: 24856577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic beryllium disease among dental technicians in Israel.
    Fireman E; Kramer MR; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):215-21. PubMed ID: 18038921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC; Quartucci C; Rakete S; Grubanovic A; Höhne K; Mangold F; Gieré R; Müller-Quernheim J; Zissel G
    Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
    Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
    Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting borderline BeLPT results.
    Middleton DC; Mayer AS; Lewin MD; Mroz MM; Maier LA
    Am J Ind Med; 2011 Mar; 54(3):205-9. PubMed ID: 20957676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.
    Cummings KJ; Deubner DC; Day GA; Henneberger PK; Kitt MM; Kent MS; Kreiss K; Schuler CR
    Occup Environ Med; 2007 Feb; 64(2):134-40. PubMed ID: 17043076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence.
    Boffetta P; Fryzek JP; Mandel JS
    Crit Rev Toxicol; 2012 Feb; 42(2):107-18. PubMed ID: 22276590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of beryllium sensitization among aluminium smelter workers.
    Taiwo OA; Slade MD; Cantley LF; Kirsche SR; Wesdock JC; Cullen MR
    Occup Med (Lond); 2010 Oct; 60(7):569-71. PubMed ID: 20610489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.
    Thomas CA; Bailey RL; Kent MS; Deubner DC; Kreiss K; Schuler CR
    Public Health Rep; 2009; 124 Suppl 1(Suppl 1):112-24. PubMed ID: 19618813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.